Epstein-Barr Virus Infection Is Not Associated with Fibroadenomas of the Breast in Immunosuppressed Patients after Organ Transplantation

Modern Pathology

Volumn 16, Issue 12, 2003, Pages 1242-1247

  Lau, Sean K ^a   Chen, Yuan Yuan ^a   Berry, Gerald J ^b   Yousem, Samuel A ^c   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Epstein Barr virus; Fibroadenoma; Immunosuppression; Transplantation

Indexed keywords

EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 4; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BREAST FIBROADENOMA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA FLANKING REGION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FIBROADENOMA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL MATRIX PROTEINS;

EID: 0346362404     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000097363.72401.00     Document Type: Article

References (46)

1. Nonoyama M, Huang CH, Pagano JS, Klein G, Singh S. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 1973;70:3265-8.
2. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 1995;103:308-15.
3. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769-74.
4. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993;143:1250-4.
5. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A 1994;91:9131-5.
6. Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, et al. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinoma, metastatic lesions, and reactive lymphocytes. Am J Pathol 1998;152:191-8.
7. Hopwood P, Crawford DH. The role of EBV in posttransplant malignancies: a review. J Clin Pathol 2000;53:248-54.
8. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, et al. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991;138:149-63.
9. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991;77:1092-5.
10. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995;332:12-8.
11. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995;332:19-25.
12. Block GE, Zlatnik PA. Giant fibroadenomata of the breast in a prepubertal girl. A case report with observations of hormonal influences. Arch Surg 1960;80:155-9.
13. Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P. Studies on clinical, hormonal, and pathological correlations in breast fibroadenomas. J Steroid Biochem 1978;9:1251-5.
14. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995;55:39-45.
15. Luqmani YA, Shousha A. Presence of Epstein-Barr virus in breast carcinoma. Int J Oncol 1996;6:899-903.
16. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999;91: 1376-81.
17. Fina F, Romain S, Ouafik LH, Palmari J, Ben Ayed F, Benharkat S, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001;84:783-90.
18. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, et al. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002;62:4876-8.
19. Chu IS, Chen CC, Chang KJ. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett 1998;124:53-7.
20. Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 1998;75:555-8.
21. Brink AATP, van den Brule AJC, van Diest P, Meijer CJLM. Re. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 2000;92:655-6.
22. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001;159:571-8.
23. Deshpande CG, Badve S, Kidwai N, Longnecker R. Lack of expression of the Epstein-Barr virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 2002;82:1193-9.
24. Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, et al. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Mod Pathol 2002;15:759-64.
25. Gan YJ, Razzouk BI, Su T, Sixbey JW. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am J Pathol 2002;160:781-6.
26. Imai S, Usui N, Sugiura M, Osato T, Sato T, Tsutsumi H, et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 1993;40:278-84.
27. Vasef MA, Kamel OW, Chen YY, Medeiros LJ, Weiss LM. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995;147:1408-15.
28. Chu PG, Chang KL, Chen WG, Chen YY, Shibata D, Hayashi K, et al. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations. Am J Pathol 1999;155:941-7.
29. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1993;1: 246-55.
30. Weiss LM, Movahed LA, Chen YY, Shin SS, Stroup RM, Bui N, et al. Detection of immunoglobulin light-chain mRNA in lymphoid tissues using a practical in situ hybridization method. Am J Pathol 1990;137:979-88.
31. Weiss LM, Chen YY. Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J Histochem Cytochem 1991;39:1237-42.
32. Chang KL, Weiss LM. The association of the Epstein-Barr virus with malignant lymphoma. Biomed Pharmacother 1996;50:459-67.
33. Gaffey MJ, Weiss LM. Association of Epstein-Barr virus with human neoplasia. Pathol Annu 1992;27:55-74.
34. Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumours. Histopathology 1996;29:297-315.
35. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A 1990;87:8790-4.
36. Sugawara Y, Mizugaki Y, Uchida T, Torri T, Imai S, Makuuchi M, et al. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999;256:196-202.
37. Koerner FC, O'Connell JX. Fibroadenoma: morphologic observations and a theory of pathogenesis. Pathol Annu 1994; 29:1-20.
38. Rolles K, Calne RY. Two cases of benign lumps after treatment with cyclosporine A [letter]. Lancet 1980;2:795.
39. Baildam AD, Higgins RM, Hurley E, Furlong A, Walls J, Venning MC, et al. Cyclosporin A and multiple fibroadenomas of the breast. Br J Surg 1996;83:1755-7.
40. Campbell A, Moazami N, Ditkoff BA, Kurtz E, Eastbrook A, Schnabel F. Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients. J Surg Res 1998; 78:27-30.
41. Weinstein SP, Orel SG, Collazzo L, Conant EF, Lawton TJ, Czerniecki B. Cyclosporin A-induced fibroadenomas of the breast: report of five cases. Radiology 2001;220:465-8.
42. Sangthawan P, Fox J, Atkins RC, Kerr PG. Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporin. Aust N Z J Surg 2002;72:222-5.
43. Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO. Induction of mammary fibroadenomas in rats by adenovirus type 9. Int J Cancer 1974;13:286-90.
44. Jonsson N, Ankerst J. Studies on adenovirus type 9-induced mammary fibroadenomas in rats and their malignant transformation. Cancer 1977;39:2513-9.
45. Javier R, Raska K, Macdonald GJ, Shenk T. Human adenovirus type 9-induced rat mammary tumors. J Virol 1991;65: 3192-202.
46. Javier R, Shenk T. Mammary tumors induced by human adenovirus type 9: a role for the viral early region 4 gene. Breast Cancer Res Treat 1996;39:57-67.